A trial looking at immunotherapy for people with some types of blood cancer using CAR T-cells (ALLCAR19)

This trial is looking at changing immune cells to recognize and attack cancer cells. The changed immune cells are called CD19CAR T-cells.

It is for people who have either:

• acute lymphoblastic leukaemia with a high risk of it coming back after treatment (high risk ALL) or ALL that has come back after treatment (relapsed)

• certain types of slow growing (low grade) non-Hodgkin lymphoma

• diffuse large B cell lymphoma (DLBCL)

• chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)

• follicular lymphoma

• mantle cell lymphoma

Please note that this trial is currently only recruiting people who have mantle cell lymphoma (MCL).